Minimal anticancer activity, despite putative antagonist status (defined in behavioral assays). Induced altered cell morphology, but did not cause cancer death. Blocked antiproliferative and cytotoxic actions of Sigma2/TMEM97 ligands. Blocked PRE-084-induced tumor growth in immune competent mouse tumor implantation model. Here, TMEM97 is linked to cancer.